As of 2025-11-18, the Relative Valuation of Cellectis SA (ALCLS.PA) is (8.27) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 3.69 EUR, the upside of Cellectis SA based on Relative Valuation is -323.8%.
The range of the Relative Valuation is (6.94) - (8.99) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 9.8x | 8.6x |
| Forward P/E multiples | 7.6x - 10.4x | 9.5x |
| Fair Price | (6.94) - (8.99) | (8.27) |
| Upside | -287.9% - -343.3% | -323.8% |
| Date | P/E |
| 2025-11-17 | -4.04 |
| 2025-11-14 | -3.73 |
| 2025-11-13 | -3.51 |
| 2025-11-12 | -3.63 |
| 2025-11-11 | -3.58 |
| 2025-11-10 | -3.51 |
| 2025-11-07 | -3.13 |
| 2025-11-06 | -3.14 |
| 2025-11-05 | -3.19 |
| 2025-11-04 | -3.22 |
| 2025-11-03 | -3.21 |
| 2025-10-31 | -3.38 |
| 2025-10-30 | -3.34 |
| 2025-10-29 | -3.61 |
| 2025-10-28 | -3.39 |
| 2025-10-27 | -3.43 |
| 2025-10-24 | -3.27 |
| 2025-10-23 | -3.26 |
| 2025-10-22 | -3.40 |
| 2025-10-21 | -3.43 |
| 2025-10-20 | -3.52 |
| 2025-10-17 | -3.73 |
| 2025-10-16 | -4.45 |
| 2025-10-15 | -3.96 |
| 2025-10-14 | -4.10 |
| 2025-10-13 | -4.27 |
| 2025-10-10 | -3.94 |
| 2025-10-09 | -3.95 |
| 2025-10-08 | -4.25 |
| 2025-10-07 | -3.56 |
| 2025-10-06 | -3.28 |
| 2025-10-03 | -3.33 |
| 2025-10-02 | -3.15 |
| 2025-10-01 | -3.04 |
| 2025-09-30 | -2.58 |
| 2025-09-29 | -2.48 |
| 2025-09-26 | -3.27 |
| 2025-09-25 | -3.25 |
| 2025-09-24 | -3.36 |
| 2025-09-23 | -3.47 |
| 2025-09-22 | -3.46 |
| 2025-09-19 | -3.36 |
| 2025-09-18 | -3.03 |
| 2025-09-17 | -2.96 |
| 2025-09-16 | -2.97 |
| 2025-09-15 | -2.92 |
| 2025-09-12 | -2.94 |
| 2025-09-11 | -3.05 |
| 2025-09-10 | -2.84 |
| 2025-09-09 | -2.71 |